CapForce IBD 50 ETF (FFTY)
| Assets | $86.91M |
| Expense Ratio | 0.80% |
| PE Ratio | 31.34 |
| Shares Out | 2.15M |
| Dividend (ttm) | $0.47 |
| Dividend Yield | 1.22% |
| Ex-Dividend Date | Dec 31, 2025 |
| Payout Frequency | Annual |
| Payout Ratio | 38.43% |
| Volume | 38,469 |
| Open | 37.55 |
| Previous Close | 38.41 |
| Day's Range | 37.32 - 38.68 |
| 52-Week Low | 31.61 |
| 52-Week High | 44.08 |
| Beta | 1.46 |
| Holdings | 65 |
| Inception Date | Apr 9, 2015 |
About FFTY
Fund Home PageThe CapForce IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 TR index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is issued by CapForce.
Top 10 Holdings
34.55% of assets| Name | Symbol | Weight |
|---|---|---|
| Travere Therapeutics, Inc. | TVTX | 3.77% |
| Liquidia Corporation | LQDA | 3.75% |
| Credo Technology Group Holding Ltd | CRDO | 3.59% |
| Carpenter Technology Corporation | CRS | 3.52% |
| Advanced Micro Devices, Inc. | AMD | 3.47% |
| Guardant Health, Inc. | GH | 3.43% |
| TG Therapeutics, Inc. | TGTX | 3.40% |
| Astera Labs, Inc. | ALAB | 3.21% |
| Kiniksa Pharmaceuticals International, plc | KNSA | 3.21% |
| Astrana Health, Inc. | ASTH | 3.20% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 31, 2025 | $0.46895 | Jan 2, 2026 |
| Dec 31, 2024 | $0.25908 | Jan 2, 2025 |
| Dec 28, 2023 | $0.15529 | Jan 2, 2024 |
| Oct 26, 2023 | $0.00214 | Oct 30, 2023 |
| Dec 29, 2022 | $0.60033 | Jan 3, 2023 |
| Dec 30, 2021 | $0.09915 | Jan 3, 2022 |
Performance
FFTY had a total return of 17.31% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.28%.
News
Capital-FORCE Welcomes IBD® 50 (FFTY) and IBD® Breakout Opportunities (BOUT) ETFs to New Rules-Based ETF Platform
LOS ANGELES--(BUSINESS WIRE)---- $BOUT #capforceetf--M2 Financial LLC, in conjunction with Capital-FORCE ETF Trust (“Capital-FORCE”), announced today the successful transition of the CapForce IBD® 50 ...
Innovator Announces Results of Special Meeting of Shareholders Relating to the Reorganizations of Innovator IBD® Breakout Opportunities ETF and Innovator IBD® 50 ETF
WHEATON, Ill., April 10, 2026 (GLOBE NEWSWIRE) -- Innovator Capital Management, LLC (“Innovator”) announced today the results of the joint special meeting of shareholders of Innovator IBD® Breakout Op...
Franklin Custodian Funds' Dynatech Fund: Don't Buy This Dip – Legacy Fund Ratings Are Misleading
A deep dive into this fund's holdings reveal a portfolio that is inferior to its benchmark and the S&P 500.